About VentriJect
VentriJect is a company based in Hellerup (Denmark) founded in 2018 by Kasper Sorensen. VentriJect has raised $3.9 million across 4 funding rounds from investors including Danmarks Eksport og Investeringsfond, Danmarks Eksport- og Investeringsfond and Investo Capital. The company has 5 employees as of December 31, 2022. VentriJect offers products and services including Seismofit® Sensor. VentriJect operates in a competitive market with competitors including Withings, Ultrahuman, Oura, iRhythm Tech and AliveCor, among others.
- Headquarter Hellerup, Denmark
- Employees 5 as on 31 Dec, 2022
- Founders Kasper Sorensen
- Stage Minicorn
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ventriject Aps
-
Annual Revenue
Not available
-
Net Profit
-$818.37 K (USD)-22as on Dec 31, 2022
-
EBITDA
-$899.86 K (USD)-16as on Dec 31, 2022
-
Total Equity Funding
$3.9 M (USD)
in 4 rounds
-
Latest Funding Round
$1.98 M (USD), Series A
Aug 12, 2025
-
Investors
Danmarks Eksport og Investeringsfond
& 5 more
-
Employee Count
5
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VentriJect
VentriJect offers a comprehensive portfolio of products and services, including Seismofit® Sensor.
Estimates VO2 max in under three minutes using AI and heart vibrations.
Funding Insights of VentriJect
VentriJect has successfully raised a total of $3.9M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.98 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VentriJect
VentriJect has secured backing from 6 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Danmarks Eksport og Investeringsfond, Danmarks Eksport- og Investeringsfond and Investo Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provision of financing, loans, equity, and insurance for Danish export and investment activities.
|
Locked | Locked | Locked | |
|
A Danish venture capital firm is focused on tech startups.
|
Locked | Locked | Locked | |
|
Financial services are provided for export and investment sectors.
|
Locked | Locked | Locked |
Investor details for VentriJect
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VentriJect
Investment portfolio details for VentriJect
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VentriJect
Detailed financials for VentriJect
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ventriject Comparisons
Peer comparison for VentriJect
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VentriJect
VentriJect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Withings, Ultrahuman, Oura, iRhythm Tech and AliveCor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Connected devices for health, sleep, and activity monitoring are developed.
|
|
| Locked | Locked | Locked |
Metabolic health is tracked via devices and fitness platforms.
|
|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Personal healthcare devices for vital monitoring are designed and produced.
|
Detailed competitors of VentriJect
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ventriject
Complete news archive for VentriJect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VentriJect
VentriJect was founded in 2018 and raised its 1st funding round 3 years after it was founded.
VentriJect is headquartered in Hellerup, Denmark.
VentriJect is a funded company, having raised a total of $3.9M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at VentriJect is 5.
VentriJect was founded in 2018 in Hellerup, Denmark, within the health technology sector. A non-wearable device is offered to measure maximal oxygen intake (VO2-max) during active or non-physical activities. An accompanying app is provided for users to track and manage their health data. Operations focus on cardiorespiratory monitoring solutions, with services aimed at fitness assessment and data logging.
VentriJect's top competitors include Withings, Ultrahuman and Oura.
VentriJect offers Seismofit® Sensor.
VentriJect has 6 investors. Key investors include Danmarks Eksport og Investeringsfond, Danmarks Eksport- og Investeringsfond, Investo Capital, TechStation, and HardTech Innovation Hub.
The valuation of VentriJect is $1.14M as of Jul 2021.